𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of Protein–Protein Interactions by Using Droplet-Based Microfluidics

✍ Scribed by Monpichar Srisa-Art; Dong-Ku Kang; Jongin Hong; Hyun Park; Robin J. Leatherbarrow; Joshua B. Edel; Soo-Ik Chang; Andrew J. deMello

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
519 KB
Volume
10
Category
Article
ISSN
1439-4227

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In Situ Fabrication of Cross-Linked Prot
In Situ Fabrication of Cross-Linked Protein Membranes by Using Microfluidics
✍ Greeshma Nair; Joseph F. Gargiuli; N. Raveendran Shiju; Zimei Rong; Evgeniy Shap 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

## Abstract We report a novel technique for preparing cross‐linked protein membranes within microchannels by using an interfacial cross‐linking reaction. Glass microchannels with a Y input were assembled by using a simple adhesive bonding technique to achieve dual, parallel laminar flows. Membrane

Bead-based protein–protein interaction a
Bead-based protein–protein interaction assays for the analysis of Rho GTPase signaling
✍ Stefanie Rimmele; Peter Gierschik; Thomas O. Joos; Nicole Schneiderhan-Marra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

## Abstract Bead‐based interaction assays are excellently suited to study protein–protein interactions, as they require only minimal amounts of sample material. Miniaturized protein–protein interaction assays were designed to analyze Rho GTPase activation based on its interaction with Rho GDI or p2

Biospecific protein immobilization for r
Biospecific protein immobilization for rapid analysis of weak protein interactions using self-interaction nanoparticle spectroscopy
✍ Aditya N. Bengali; Peter M. Tessier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 918 KB

## Abstract “Reversible” protein interactions govern diverse biological behavior ranging from intracellular transport and toxic protein aggregation to protein crystallization and inactivation of protein therapeutics. Much less is known about weak protein interactions than their stronger counterpart